Proposed Local Coverage Determinations (LCDs) Released for Comment - Enteral Nutrition, Osteogenesis Stimulators, Parenteral Nutrition and Seat Lift Mechanisms

Posted February 9, 2023

The Centers for Medicare and Medicaid Services (CMS) assigned to the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) the task of developing LCDs for Durable Medical Equipment, Prostheses, Orthoses, and Supplies (DMEPOS). The DME MACs are proposing four LCDs as described below:

Enteral Nutrition (DL38955) - Proposed addition of GA, GY GZ, and KX modifiers to the Coding Information section of the LCD.
Osteogenesis Stimulators (DL33796) - Proposed addition of GA, GZ and KX modifiers to the Coding Information section of the LCD.
Parenteral Nutrition (DL38953) - Proposed addition of GA, GY, GZ and KX modifiers to the Coding Information section of the LCD.
Seat Lift Mechanisms (DL33801) - Proposed addition of GA, GZ and KX modifiers to the Coding Information section of the LCD.

Stakeholders may read the details of each proposed LCD posted on the Medicare Coverage Database by referencing the LCD ID number in the search field. The entire proposed LCD(s) should be reviewed prior to the submission of written comments.

We are soliciting comments on the proposed LCDs from stakeholders (including, but not limited to, clinicians, manufacturers, suppliers, and other parties who care for Medicare beneficiaries). You should be very specific in your comments, and if possible, offer suggestions that may address your concerns. We encourage a written response regardless of your agreement or disagreement with the proposed LCDs.

In your comments, please be sure to disclose all conflicts of interest you have with any manufacturer(s) or supplier(s) of the DMEPOS items addressed in the above LCDs.

All comments will be collected at a single point of contact for each proposed LCD. Comments that address more than one proposed LCD should be submitted to each LCD email address for which comments are being made. Do not include any protected health information (PHI) or personally identifiable information (PII). Please submit your comments electronically to the DME MACs at the applicable email address(es) listed below no later than Saturday, March 25, 2023 at 5 pm ET.

Enteral Nutrition (DL38955): ENTLCDComments@cgsadmin.com
Osteogenesis Stimulators (DL33796): OsteoRecon@noridian.com
Parenteral Nutrition (DL38953):  PENRecon@noridian.com
Seat Lift Mechanisms (DL33801): SeatLiftRecon@noridian.com

Suppliers and clinicians are cautioned not to make any changes based upon information contained in a proposed LCD. The content of a proposed LCD may be revised based upon the written comments received during the comment period. When all written comments have been reviewed, revisions will be considered.

*IMPORTANT: The DME MACs will host a virtual open meeting to further solicit input from stakeholders for the proposed LCDs. The virtual meeting will take place on March 23, 2023. For details regarding participation in the virtual open meeting, refer to the open meeting announcement article posted at Open Meeting Announcement - Enteral Nutrition,  Osteogenesis Stimulators, Parenteral Nutrition and Seat Lift Mechanisms Proposed Local Coverage Determinations (LCDs).

Refer to each DME MAC website for additional information, including access to the proposed LCDs.

Thank you for your participation in our policy development process.

Smitha M. Ballyamanda, MD, CAQSM
Medical Director, DME MAC Jurisdiction A
Noridian Healthcare Solutions, LLC

Sunil V. Lalla, MD, FACS, CPC
Medical Director, DME MAC Jurisdiction B
CGS Administrators, LLC

Robert D. Hoover, Jr., MD, MPH, FACP
Medical Director, DME MAC Jurisdiction C
CGS Administrators, LLC

Angela S. Jenny, DO
Medical Director, DME MAC, Jurisdiction D
Noridian Healthcare Solutions, LLC

 

Last Updated $dateUtil.getDate( $modifieddate , "MMM dd , yyyy" , $locale , $tzone )